Showing results (331-340 of 635) with videos related to

Sort By:
Pageof 64
Circulation. Heart Failure|November 22, 2021
Mode of Death in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF TrialAkshay S Desai, Muthiah Vaduganathan, John G Cleland, et al.
JACC. Heart Failure|January 5, 2019
Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney DiseaseIris E Beldhuis, Peder L Myhre, Brian Claggett, et al.
American Heart Journal|April 30, 2017
The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) TrialCarolyn Y Ho, John J V McMurray, Allison L Cirino, et al.
ESC Heart Failure|December 24, 2022
Potassium reduction with sodium zirconium cyclosilicate in patients with heart failureJean-Claude Tardif, Jean Rouleau, Glenn M Chertow, et al.
European Journal of Heart Failure|October 2, 2015
Increased risk of stroke with darbepoetin alfa in anaemic heart failure patients with diabetes and chronic kidney diseaseNatalie A Bello, Eldrin F Lewis, Akshay S Desai, et al.
JACC. Advances|June 28, 2024
Effects of Sacubitril/Valsartan vs Valsartan in De Novo vs Acute on Chronic HFpEF and HFmrEFEvan M Murray, Derek Cyr, Marat Fudim, et al.
European Journal of Heart Failure|February 10, 2021
Dynamic changes in cardiovascular and systemic parameters prior to sudden cardiac death in heart failure with reduced ejection fraction: a PARADIGM-HF analysisLuis E Rohde, Muthiah Vaduganathan, Brian L Claggett, et al.
Journal of Cardiac Failure|May 23, 2023
Duration of Heart Failure With Preserved Ejection Fraction and Outcomes With Sacubitril/Valsartan: Insights From the PARAGON-HF TrialJohn W Ostrominski, Brian L Claggett, Milton Packer, et al.
Circulation. Heart Failure|June 22, 2019
Utility of the Cardiovascular Physical Examination and Impact of Spironolactone in Heart Failure With Preserved Ejection FractionSenthil Selvaraj, Brian Claggett, Sanjiv J Shah, et al.
American Heart Journal|September 5, 2021
Population health management of low-density lipoprotein cholesterol via a remote, algorithmic, navigator-executed programJorge Plutzky, Mark D Benson, Kira Chaney, et al.
Pageof 64